WHOLE-GENOME EMOTIONAL-CLASSIFICATION LAW IN RUSSIA

1. INTRODUCTION

Whole-genome emotional classification refers to the proposed use of an individual's complete genomic information, artificial intelligence (AI), computational biology and behavioural data to classify emotional characteristics, psychological tendencies or potential emotional responses. Such systems may attempt to associate genetic variations with characteristics such as stress sensitivity, emotional regulation, anxiety susceptibility, impulsivity and behavioural responses.

The technology raises significant legal and ethical concerns because emotional characteristics cannot reliably be determined from an individual's genome alone. Environmental conditions, personal experiences, neurological processes and social circumstances also influence emotional states.

Russia does not have a dedicated federal statute specifically regulating whole-genome emotional classification. Nevertheless, activities involving genomic information, psychological assessment, medical diagnosis, biometric identification and algorithmic profiling may be governed by existing constitutional, healthcare, personal-data and information-security legislation.

2. PRINCIPAL LEGAL FRAMEWORK

A. CONSTITUTION OF THE RUSSIAN FEDERATION

Several constitutional provisions are relevant:

Article 21: Protection of human dignity.

Article 23: Right to privacy and protection of personal and family secrets.

Article 24: Restrictions on collecting, storing, using and disseminating information concerning private life without an appropriate legal basis.

Article 28: Freedom of conscience and belief.

Article 45: State protection of human rights and freedoms.

These provisions provide constitutional safeguards against unjustified collection, disclosure and discriminatory use of genomic and psychological information.

B. FEDERAL LAW NO. 152-FZ OF 27 JULY 2006 ON PERSONAL DATA

This legislation is particularly important because whole-genome emotional classification requires processing extensive personal information.

Article 10 regulates special categories of personal data, including information concerning health.

Article 11 regulates biometric personal data used to establish an individual's identity.

A genetic dataset is not automatically biometric personal data in every circumstance. Its classification depends on its nature and purpose of processing.

Organisations must establish lawful grounds for collecting and processing genomic information and implement appropriate security safeguards.

C. FEDERAL LAW NO. 323-FZ OF 21 NOVEMBER 2011 ON THE FUNDAMENTALS OF HEALTH PROTECTION

Relevant provisions include:

Article 13: Medical confidentiality.

Article 20: Informed voluntary consent.

Article 22: Patient rights to information concerning health.

Article 37: Organisation of medical care.

Article 79: Responsibilities of medical organisations.

Where genomic emotional classification is undertaken as part of medical diagnosis or treatment, applicable healthcare requirements must be observed.

D. FEDERAL LAW NO. 149-FZ OF 27 JULY 2006

This law regulates information technologies and information protection.

It is relevant to computational genomic platforms, AI-based classification databases and digital psychological profiling systems.

E. FEDERAL LAW NO. 187-FZ OF 26 JULY 2017

This legislation establishes requirements concerning the security of critical information infrastructure.

Its application depends on whether the relevant organisation and information system fall within the statutory definition and applicable regulatory criteria.

3. LEGAL GOVERNANCE OF WHOLE-GENOME EMOTIONAL CLASSIFICATION

A. GENOMIC DATA COLLECTION AND PROCESSING

Whole-genome analysis involves the collection and computational processing of extensive genetic information.

Organisations conducting such activities should establish:

A clearly defined and lawful processing purpose.

An appropriate legal basis for collecting genomic information.

Appropriate consent where required.

Secure genomic-data storage.

Restrictions on unauthorised third-party access.

Appropriate retention and deletion procedures.

Compliance with applicable cross-border data-transfer requirements.

Genomic information may reveal hereditary conditions and information concerning biological relatives. Therefore, its processing creates privacy risks beyond the individual who provides the biological sample.

B. EMOTIONAL CLASSIFICATION AND SCIENTIFIC RELIABILITY

A fundamental regulatory issue is whether genomic information can scientifically support emotional classification.

Whole-genome information cannot independently establish that a person is aggressive, emotionally unstable, dishonest, psychologically vulnerable or predisposed to particular social behaviour.

Genetic associations are generally probabilistic and influenced by environmental and biological factors.

Consequently, organisations should not present speculative genetic correlations as established psychological diagnoses.

C. INFORMED CONSENT AND HUMAN AUTONOMY

Article 20 of Federal Law No. 323-FZ establishes informed voluntary consent requirements for medical intervention.

Where whole-genome analysis constitutes medical intervention, individuals should receive information concerning:

The purpose of genomic analysis.

The nature of emotional classification.

Scientific limitations and uncertainty.

Potential incidental findings.

Storage and future use of genetic information.

Possible disclosure to third parties.

Potential consequences of psychological profiling.

Consent to medical genetic testing should not automatically authorise unrelated behavioural surveillance or commercial profiling.

D. ARTIFICIAL INTELLIGENCE AND ALGORITHMIC PROFILING

AI-based genomic classification may create risks of inaccurate categorisation, discrimination and automated decision-making.

Russian law does not establish a comprehensive, standalone regulatory regime specifically for AI-based emotional classification using whole-genome data.

Nevertheless, applicable personal-data, healthcare, consumer-protection and information-security requirements remain relevant.

Organisations should implement human oversight, validation procedures, documented classification methodologies and mechanisms for correcting inaccurate results.

4. EMPLOYMENT, INSURANCE AND DISCRIMINATION RISKS

Whole-genome emotional classification becomes particularly sensitive when employers, insurers or educational institutions use genetic predictions to evaluate individuals.

Potentially problematic practices include:

Rejecting job applicants based on predicted emotional instability.

Assigning employees to positions based on speculative genetic personality classifications.

Increasing insurance premiums based on unsupported behavioural predictions.

Restricting educational opportunities through genetic psychological profiling.

Disclosing emotional-risk classifications without lawful justification.

Article 3 of the Russian Labour Code prohibits discrimination in employment on grounds unrelated to employees' professional qualities.

Article 86 regulates the processing and protection of employees' personal data.

These provisions are relevant when employers attempt to use genetic information to make employment decisions.

5. GENETIC PRIVACY AND MEDICAL CONFIDENTIALITY

Article 13 of Federal Law No. 323-FZ protects medical confidentiality, while Federal Law No. 152-FZ establishes personal-data processing requirements.

Organisations should distinguish between:

Genetic information obtained for clinical diagnosis.

Genomic information processed for scientific research.

Psychological information collected through clinical assessment.

Behavioural information generated through digital monitoring.

Emotional classifications produced by AI systems.

These categories may overlap, but their legal treatment depends on their content, purpose and processing circumstances.

Unauthorised disclosure of genomic emotional classifications may expose individuals to privacy violations, reputational harm and discriminatory treatment.

6. RELEVANT CASE LAWS AND JUDICIAL AUTHORITIES

There is no established body of reported Russian judicial decisions specifically addressing whole-genome emotional classification. The following decisions provide relevant constitutional and comparative legal principles.

A. RUSSIAN JUDICIAL AUTHORITIES

1. Constitutional Court of the Russian Federation, Judgment No. 8-P of 3 February 2010

This judgment provides broader constitutional context concerning individual rights and healthcare regulation. Its principles may be relevant when assessing state interference with personal medical information. It is not a direct genomic-classification decision.

2. Constitutional Court of the Russian Federation, Judgment No. 15-P of 2020

This judgment addresses the relationship between public interests and individual constitutional rights. Its broader reasoning is relevant by analogy when evaluating the proportionality of governmental measures involving sensitive personal information.

B. EUROPEAN COURT OF HUMAN RIGHTS AUTHORITIES

The following decisions are comparative authorities. Their applicability to contemporary Russian proceedings must be considered in light of Russia's withdrawal from the European Convention on Human Rights and applicable temporal and domestic-law rules.

3. S. and Marper v. United Kingdom (2008), Applications Nos. 30562/04 and 30566/04

The Court examined the retention of DNA profiles and biological samples by public authorities.

Legal principle: Genetic information requires substantial privacy safeguards, and indiscriminate retention may violate the right to private life.

Relevance: Whole-genome emotional classification creates comparable concerns involving the collection, retention and secondary use of genetic information.

4. Z v. Finland (1997), Application No. 22009/93

The Court emphasised the importance of medical confidentiality under Article 8 of the European Convention.

Legal principle: Confidentiality of health information is essential to protecting individual privacy.

Relevance: Emotional classifications derived from genomic and medical information require appropriate confidentiality protections.

5. Avilkina and Others v. Russia (2013), Application No. 1585/09

The Court considered disclosure of confidential medical information to public authorities.

Legal principle: Disclosure of medical information must satisfy appropriate legal safeguards and proportionality requirements.

Relevance: Genetic psychological profiles should not be disclosed without an adequate legal basis.

6. Pretty v. United Kingdom (2002), Application No. 2346/02

The Court considered individual autonomy and personal decision-making under Article 8.

Legal principle: Personal autonomy forms an important aspect of private life.

Relevance: Individuals should retain meaningful control over participation in genetic and psychological assessment, subject to applicable law.

7. Jehovah's Witnesses of Moscow and Others v. Russia (2010), Application No. 302/02

The Court examined freedom of religion and the autonomy of individuals and religious communities.

Legal principle: State interference with personal choices requires appropriate justification.

Relevance: The decision provides broader comparative principles concerning personal autonomy, although it does not concern genetic profiling.

7. LEGAL LIABILITY AND REGULATORY ENFORCEMENT

Organisations involved in unlawful whole-genome emotional classification may face several forms of liability.

A. PERSONAL-DATA VIOLATIONS

Unlawful processing or disclosure of genetic and psychological information may attract administrative liability under Article 13.11 of the Russian Code of Administrative Offences.

B. MEDICAL CONFIDENTIALITY VIOLATIONS

Unauthorised disclosure of medical genetic information may violate Article 13 of Federal Law No. 323-FZ and other applicable legal provisions.

C. EMPLOYMENT DISCRIMINATION

Employers using speculative emotional classifications to restrict employment opportunities may face challenges under Article 3 of the Labour Code.

D. MEDICAL NEGLIGENCE

Where an inaccurate genomic classification is incorporated into medical diagnosis or treatment and causes harm, civil liability may arise. In serious circumstances, applicable criminal provisions may also become relevant.

E. UNLAWFUL INFORMATION PROCESSING

Unauthorised access, misuse or disclosure of genomic information may trigger additional administrative or criminal consequences depending on the conduct and resulting harm.

8. PRACTICAL COMPLIANCE REQUIREMENTS

Organisations developing or operating whole-genome emotional-classification systems in Russia should:

Establish a specific and lawful purpose for genomic-data processing.

Obtain appropriate informed consent where legally required.

Distinguish genetic information from biometric identification data.

Avoid presenting uncertain genetic associations as definitive psychological diagnoses.

Validate scientific and computational classification methodologies.

Implement human oversight of consequential decisions.

Restrict access to genomic and psychological profiles.

Comply with Federal Law No. 152-FZ.

Maintain appropriate medical-confidentiality safeguards.

Prohibit unjustified employment discrimination based on genetic predictions.

Establish procedures for correcting inaccurate classifications.

Conduct regular privacy and cybersecurity audits.

9. CONCLUSION

Whole-genome emotional classification in Russia presents significant legal challenges involving genetic privacy, personal autonomy, scientific reliability, medical confidentiality and algorithmic discrimination.

Although Russia does not currently have a dedicated federal statute specifically regulating genomic emotional classification, Federal Laws No. 152-FZ, 323-FZ and 149-FZ, together with constitutional protections and employment legislation, provide an important regulatory foundation.

The principal legal concern is preventing speculative genetic interpretations from becoming instruments of psychological discrimination, unjustified surveillance or restrictions on individual freedom. Responsible governance requires lawful data processing, scientifically defensible interpretations, informed consent, confidentiality and meaningful human oversight.